Old Web
English
Sign In
Acemap
>
authorDetail
>
László Fehér
László Fehér
Janssen-Cilag
Antipsychotic
Medicine
Discontinuation
Olanzapine
Risperidone
4
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis.
2021
PLOS ONE
Peter Dome
Péter Kunovszki
Péter Takács
László Fehér
T. Balazs
Károly Dede
Siobhán Mulhern-Haughey
Sébastien Barbreau
Zoltan Rihmer
Show All
Source
Cite
Save
Citations (1)
[Become the expert and embrace a positive attitude: communication strategies for discussing long-acting injectable antipsychotic treatment with patients living with schizophrenia].
2020
László Fehér
Lucie Kalisova
Slávka Dubinská
Levente Herman
Jelena Sušac
Michal Risler
Annette Wooller
Tamás Tényi
Show All
Source
Cite
Save
Citations (0)
Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary
2019
PLOS ONE
Péter Takács
Pál Czobor
László Fehér
J Gimesi-Országh
P Fadgyas-Freyler
M. Bacskai
P. Rakonczai
A Borsi
R. Hegyi
T. Németh
J. Sermon
István Bitter
Show All
Source
Cite
Save
Citations (7)
Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: A nationwide study in Hungary
2013
European Neuropsychopharmacology
István Bitter
Lajos Katona
János Zámbori
P Takács
László Fehér
Joris Diels
M. Bacskai
Zsolt Láng
Gergely Gyáni
Pál Czobor
Show All
Source
Cite
Save
Citations (24)
1